By univariate analysis the clinical manifestations associated to IL-17A, TGFβ, FGF2 and CTGF production by PBMCs were interstitial lung disease (ILD), PAH and DU (p<0,01). This evidence concerns the gene CCN2 and pulmonary arterial hypertension.